Health and Disease Monitoring in the Heart and the Aorta Based on Model-Based Ballistocardiogram Analysis


Executive Summary


Ballistocardiogram (BCG) is a recording of cardiac force exerted on the body due to the ejection of blood by the heart. Researchers at Michigan State University, University of Maryland, and Georgia Institute of Technology have developed a new method to analyze the BCG signal to detect abnormalities of blood pressure associated with proximal and distal arteries.  This novel method allows for a more effective, low-cost, and non-intrusive assessment and screening of diseases in the heart and arteries.


Description of Technology


This invention concerns a method to analyze ballistocardiogram (BCG) signal using a novel mathematical model. This technology can improve the BCG monitors currently available on the market by extracting more useful physiological information from the BCG signal, making possible a higher quality assessment and screening of the health and disease in the heart and aorta.


Key Benefits

  • Enables a more powerful analysis of the physiological information from the BCG signal
  • Low cost and non-intrusive
  • Easy to implement with existing BCG solutions



  • Health and disease monitoring in the heart and arteries


Patent Status: 


Patent pending.


Licensing Rights Available


Full licensing rights available.


Inventors: Dr. Ramakrishna Mukkamala, Dr. Omer Inan, Dr. Jin-Oh Hahn, Dr. Chang-Sei Kim, Dr. Stephanie Ober



Patent Information:


For Information, Contact:

Brian Copple
Technology Manager
Michigan State University